HOME > Investor relations > Financial Highlights (Consolidated)
FY12/18 | FY12/19 | FY12/20 | FY12/21 | FY12/22 | Net Sales | 36,145 | 38,393 | 26,805 | 25,453 | 26,530 | Operating Income | 2,259 | 1,458 | -2,971 | -3,343 | -1,886 |
---|---|---|---|---|---|
EBITDA | 3,607 | 2,922 | -1,585 | -2,085 | -926 |
Net Income | 911 | -103 | -4,998 | -489 | -3,402 |
FY12/18 | FY12/19 | FY12/20 | FY12/21 | FY12/22 | |
---|---|---|---|---|---|
Earnings Per Share | 21.25 | -2.40 | -115.82 | -11.23 | -77.21 |
ROE | 9.6% | -1.1% | -140.4% | -12.5% | -598.0% |
ROA | 10.1% | 3.4% | -11.8% | 6.7% | -3.4% |
Operating Income to Sales Ratio | 6.3% | 3.8% | -11.1% | -13.1% | -7.1% |
The information contained within this site is not meant to be a solicitation to purchase our shares. We ask any users of our site to refrain from basing any investment decisions upon our company using the information contained within our site alone.